Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target (Q37596851)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 October 2013
edit
Language Label Description Also known as
English
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target
scientific article published on 03 October 2013

    Statements

    Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit